Clinical Laboratory Improvement Advisory Committee: Notice of Charter Renewal

---
identifier: "/us/fr/02-4024"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Clinical Laboratory Improvement Advisory Committee: Notice of Charter Renewal"
title_number: 0
title_name: "Federal Register"
section_number: "02-4024"
section_name: "Clinical Laboratory Improvement Advisory Committee: Notice of Charter Renewal"
positive_law: false
currency: "2002-02-20"
last_updated: "2002-02-20"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "02-4024"
document_type: "notice"
publication_date: "2002-02-20"
agencies:
  - "Health and Human Services Department"
  - null
fr_citation: "67 FR 7699"
fr_volume: 67
---


#  Clinical Laboratory Improvement Advisory Committee: Notice of Charter Renewal

This gives notice under the Federal Advisory Committee Act (Pub. L. 92-463) of October 6, 1972, that the Clinical Laboratory Improvement Advisory Committee, of the Centers for Disease Control and Prevention (CDC), of the Department of Health and Human Services, has been renewed for a 2-year period extending through February 19, 2004.

**For further information contact:**

Edward L. Baker, M.D., Executive Secretary, Clinical Laboratory Improvement Advisory Committee, CDC, 4770 Buford Hwy, NE, m/s K-36, Atlanta, Georgia 30333. Telephone 770/488-2402, fax 770/488-2420, e-mail *[email protected]* .

The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Dated: February 13, 2002.

Alvin Hall,

Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.